POU5F1P2

Across TCGA pan-cancer cohorts, POU5F1P2 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated POU5F1P2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher POU5F1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated POU5F1P2 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

BLCA, TGCT, and LUAD are the cancer types where POU5F1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.052	0.688	<.001	99	view →
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	72	view →
LUAD	OS	Tertile	III,IV	0.223	0.677	.006	36	view →
SARC	DFS	Tertile	All	0.182	0.546	.004	18	view →
KIRP	OS	Tertile	All	0.738	0.950	.006	12	view →
STAD	OS	Tertile	IV	0.790	0.276	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

POU5F1P2–BLCA (OS)

Open the BLCA breakdown →